China, Sanofi and Insulin

Sanofi Unveils $1 Billion China Investment to Boost Production
Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest single investment in China to date and part of a broader push to boost manufacturing capacity in Asia.
Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China
The French drugmaker said that the investment of about 1 billion euros will enhance the production and manufacturing of insulin, focusing on serving local diabetic patients.
Sanofi to spend $1.05B building insulin manufacturing base in China, WSJ says
Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal
Sanofi pours $1 billion into China for insulin plant
Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new insulin manufacturing facility in Beijing, reflecting increasing demand for diabetes treatments in the country.
Sanofi charts biggest China investment to date with plans for €1B insulin 'manufacturing base' in Beijing
Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing outlay in China, marking its biggest investment in the country to date. | Sanofi is laying out roughly 1 billion euros ($1.
Sanofi To Invest $1.05 Bln For New Insulin Production Base In China
French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in
Sanofi announces its biggest China investment deal amid China-EU trade tensions
Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, which will ...
BioProcess International17h
Sanofi opens AI-powered $595m facility in Singapore
In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, Singapore.
Healthcare Dive8d
Sanofi joins J&J, Eli Lilly in proposing 340B rebate model
Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...
ENDPOINTS NEWS2d
Sanofi ear­marks €1B for new in­sulin pro­duc­tion fac­to­ry in Bei­jing
Sanofi has made its single largest investment in China to date by pouring roughly €1 billion ($1.05 billion) into a new ...
STAT12d
Sanofi plans to change payment terms for 340B hospitals
Sanofi is the third company - along with J&J and Eli Lilly - to attempt to change the way it pays for medicines under the ...
Sanofi CEO Paul Hudson takes inspiration from ‘Fight Club’ to get his team hooked on AI
Hudson says many CEOs are scared of AI, comparing it to The Terminator’s John Connor traveling back in time to stop the rise ...
At Sanofi, there are diverse pathways to success
As the French pharmaceutical firm does at its facilities around the world, Sanofi aims to create lateral as well as vertical ...
devdiscourse2d
Global Health Developments: From Sanofi's Expansion to Bird Flu Alert
A roundup of significant health updates globally includes Sanofi's major investment in China, New Zealand suspending poultry ...